MedImmune, Cambridge, United Kingdom.
Ann N Y Acad Sci. 2012 May;1255:30-44. doi: 10.1111/j.1749-6632.2012.06561.x.
This meeting report highlights the main topics presented at the conference "Chronic Inflammatory and Neuropathic Pain," convened jointly by the New York Academy of Sciences, MedImmune, and Grünenthal GmbH, on June 2-3, 2011, with the goal of providing a conducive environment for lively, informed, and synergistic conversation among participants from academia, industry, clinical practice, and government to explore new frontiers in our understanding and treatment of chronic and neuropathic pain. The program included leading and emerging investigators studying the pathophysiological mechanisms underlying neuropathic and chronic pain, and experts in the clinical development of pain therapies. Discussion included novel issues, current challenges, and future directions of basic research in pain and preclinical and clinical development of new therapies for chronic pain.
本会议报告重点介绍了 2011 年 6 月 2 日至 3 日由纽约科学院、MedImmune 和 Grünenthal GmbH 联合召开的“慢性炎症和神经病理性疼痛”会议上提出的主要议题,旨在为来自学术界、工业界、临床实践和政府的与会者提供一个有利的环境,以便他们就我们对慢性和神经病理性疼痛的理解和治疗的新领域进行生动、知情和协同的对话。该计划包括研究神经病理性和慢性疼痛病理生理机制的领先和新兴研究人员,以及疼痛治疗临床开发方面的专家。讨论包括疼痛基础研究的新问题、当前挑战和未来方向,以及慢性疼痛新疗法的临床前和临床开发。